Product Program year 2019 Source: CMS Open Payments

Synvisc-One

Device Osteoarthritis

Open in the dashboard

General payments

$108,150

2,990 payments

Research payments

$42,113

1 payment

Through program year 2019, $108,150 in general payments and $42,113 in research payments were reported against Synvisc-One (Osteoarthritis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $108,150 2,990
2019 Research $42,113 1

Breakdown

Who paid General payments · program year 2019
  1. Sanofi-Aventis U.S. LLC $107,982 2,988 payments
  2. Genzyme Corporation $168 2 payments
Top recipients General payments · program year 2019
  1. Jack Bert Orthopaedic Surgery · Woodbury, MN $18,748 17% · 9 payments
  2. Andrew Spitzer Orthopaedic Surgery · Los Angeles, CA $10,153 9% · 1 payment
  3. Scott Hrnack Sports Medicine · Fort Worth, TX $7,471 7% · 2 payments
  4. Robert Dimeff Sports Medicine · Dallas, TX $6,765 6% · 1 payment
  5. Roy Altman Rheumatology · Newhall, CA $5,028 5% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Orthopaedic Surgery $53,660 53% · 887 practitioners
  2. Sports Medicine Orthopaedic Surgery $11,355 11% · 158 practitioners
  3. Rheumatology Internal Medicine $9,264 9% · 184 practitioners
  4. Sports Medicine Family Medicine $8,777 9% · 94 practitioners
  5. Physical Medicine & Rehabilitation $7,089 7% · 87 practitioners

The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Minnesota $26,530 25% · 13 recipients
  2. Texas $23,097 21% · 205 recipients
  3. California $22,286 21% · 205 recipients
  4. New York $3,670 3% · 108 recipients
  5. Pennsylvania $3,139 3% · 127 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

2,990 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record